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Abstract
A Kuhnian approach to research assessment requires us to consider that the important scientific breakthroughs that drive
scientific progress are infrequent and that the progress of science does not depend on normal research. Consequently,
indicators of research performance based on the total number of papers do not accurately measure scientific progress.
Similarly, those universities with the best reputations in terms of scientific progress differ widely from other universities in
terms of the scale of investments made in research and in the higher concentrations of outstanding scientists present, but
less so in terms of the total number of papers or citations. This study argues that indicators for the 1% high-citation tail of
the citation distribution reveal the contribution of universities to the progress of science and provide quantifiable
justification for the large investments in research made by elite research universities. In this tail, which follows a power low,
the number of the less frequent and highly cited important breakthroughs can be predicted from the frequencies of papers
in the upper part of the tail. This study quantifies the false impression of excellence produced by multinational papers, and
by other types of papers that do not contribute to the progress of science. Many of these papers are concentrated in and
dominate lists of highly cited papers, especially in lower-ranked universities. The h-index obscures the differences between
higher- and lower-ranked universities because the proportion of h-core papers in the 1% high-citation tail is not
proportional to the value of the h-index.
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Introduction
‘‘Government policy-makers, corporate research managers, and
university administrators need valid and reliable S&T indicators
for a variety of purposes: for example, to measure the effectiveness
of research expenditures, identify areas of strength and excellence,
set priorities for strategic planning, monitor performance relative
to peers and competitors, and target emerging specialties and new
technologies for accelerated development.’’ So begins a paper by
Garfield and Welljams-Dorof [1], and the essence of this idea can
be found in the introductions to countless papers published before
and since. Consistent with this idea, many research indicators have
been developed (see, for example [2–4]). It is unclear, however,
whether the indicators currently used accurately measure all that
governments and research administrators need to know, or
whether such indicators are always correctly interpreted and
applied by governments and research administrators [5–7].
The Spanish government, for example, recently announced that
the quality of scientific research in Spain had overtaken that of
Switzerland [8], but this statement is inconsistent with the role
research plays in the economic realities of the respective countries.
While the responsibility for any misstatement would lay exclusively
with its author, if it is based on a research indicator–in this case,
citation counts of all published papers–the validity of that indicator
as a numerical measure of research performance should be
brought into question. The use of indicators of research
performance based on measures such as the numbers of all papers
published and their subsequent citations contributes to not only
misleading conclusions about a country’s research performances
but also to the notion that elite research institutions are not using
their research investment funds in an efficient manner.
Considering the highest- and lowest-ranked universities in [9],
MIT’s research revenues exceed 1.3 billion US dollars per year
(http://web.mit.edu/facts/financial.html, accessed on August
2011), whereas the equivalent figure for Complutense University
of Madrid is 21 million euros (approximately, 27 million US
dollars; http://www.redotriuniversidades.net/, accessed on Au-
gust 2011). The comparison of these figures leads to the conclusion
that the difference in research performance between these two
universities is not best indicated by the ratio of the number of
publications or of the other indicators based on the total number
of publications, which may have values of 2–3 (for example:
Academic Ranking of World Universities 2010, PUB score, http://www.
arwu.org/ARWU2010.jsp, accessed on August 2011; Excellence
Rate Report, http://www.scimagoir.com, downloaded November,
2011). It is, of course, difficult to make comparisons regarding
research funding and output [10], and the differences in the
accounting methods across institutions must be corrected before
making comparisons. However, even having compensated for
those differences, the investment ratio between MIT and
Complutense University is still greater than 10:1. In addition,
the high number of researchers having received Nobel prizes or
other awards [11] and with a high number of citations [12] at
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MIT suggests that the institution tends to hire high-level
researchers in contrast with the suboptimal methods for researcher
selection to which Spanish universities adhere [13]. All this
suggests that differences in research performance between MIT
and Complutense University should be even greater than those
suggested by the differences in funding and ought not to be
expressed as simply a ratio of 3.0. Another way to view this issue is
calculating the ratio of research investment per paper for the two
institutions. This calculation reveals that the MIT’s cost of one
paper is seven times higher than in Complutense University, which
suggests that those papers coming out of MIT are not comparable
to those coming out of Complutense University.
These examples illustrate that some research indicators may be
problematic at both country and university levels. Although the
problems can be investigated at both levels, the university level is
easier to investigate because universities are research units more
homogeneous than countries, where very different institutions
coexist. Moreover, it is easy to select a sample of universities that
are very different in research activity and similar in size to simplify
the analysis of the results.
To evaluate overall research performance, the x-index was
recently formulated using a statistical procedure which optimized
the correlation of the indicator with the number of Nobel Prize
achievements [9]. The x-index only considers the papers that are
included in the world’s top 1% of cited papers [9] and not all these
papers. In particular, multinational and review papers are not
counted, and a subtraction term is included in the formula to
statistically discount the papers that report methods, clinical trials,
and statistics (MCTS papers). Although the statistical procedure to
formulate the x-index was effective, it does not address conceptual
questions about the papers that are not counted. Besides, it does
not provide any indication about the number of papers that are
counted with reference to the total number of papers in
universities of different research levels. However, this is informa-
tion is necessary to establish a solid scientific background for
evaluations based on the world’s top 1% of cited papers.
Considering these issues, this study aims to answer three specific
questions regarding the x-index, or any other research indicator
based on highly cited papers: (i) Is the exclusion of 99% of the
published papers supported by conceptual or empirical reasons?
(ii) Which is the proportion of multinational, reviews, and MCTS
papers in highly cited papers? (iii) Is it possible to simplify the x-
index formula for universities? The first question is at the basis of
research evaluations and it will be addressed from a general point
of view. The other two questions are purely technical and they will
be addressed studying 18 universities of different research levels.
The Basis of Research Evaluation: A Kuhnian View of
Research Performance
The majority of research papers that are published every year
receive an ephemeral attention from researchers and no attention
from the society, but nevertheless, relevant papers are somehow
dependent from apparently irrelevant papers. In principle, this
situation resembles a soccer match, where many passes are
necessary to strike a goal. The number of passes can be counted,
but this number does not determine the winner of the match,
which is determined by counting the very low frequency events in
which the ball is kicked to the goal. Similarly in research, many
papers are necessary to make discoveries, but very few report
actual discoveries. Unlike soccer, however, in research, there are
discoveries of different levels that cannot be easily counted or
added up together. Therefore, valid and reliable indicators are
required to estimate the capacity of countries and institutions to
drive scientific progress.
Output indicators of scientific research performance were
developed many years ago [14]. Although there are many types,
most such indicators are based on the total number of published
papers. At a first view, this approach seems to be in contrast with
the notion that science does not progress linearly, via a steady
accumulation of published information. Early views of this notion
were established by James McKeen Cattell (for a review see [15])
and by Jose´ Ortega y Gasset [16], but it was Thomas Kuhn [17]
who formalized it in his seminal work, The Structure of Scientific
Revolutions, in this study coining the terms ‘‘normal’’ and
‘‘revolutionary’’ sciences. Kuhn demonstrated that only revolu-
tionary science exerts change on the fundamental structures of
science through ‘‘paradigm shifts.’’ As an extension of this central
idea, it may be added that, in the short run, important paradigm
extensions drive a type of scientific progress that the society
appreciates and that must be considered to estimate research
performance.
An illustrative example of scientific progress that is based on
paradigm extension can be taken from a cancer treatment
breakthrough, the use of imatinib mesyalate in the treatment of
chronic myelogenous leukemia. The excellent clinical performance
of this drug is based on two biological features: a chromosomal
translocation that creates a fusion gene, which is vital for the
expansion of cancer cells, and the inhibition of the product of this
gene by imatinib [18]. The discoveries of these features constituted
important breakthroughs in cancer research, but neither discovery
represented a paradigm shift. Even the concept of a drug able to
kill cancer cells without damaging normal cells is only an extension
of the ‘‘magic bullet’’ concept popularized by Paul Ehrlich one
hundred years ago [19]. The paradigm shift occurred when Paul
Ehrlich developed Salvarsan to treat syphilis and not with the
present-day development of imatinib.
This example can also be used to answer the question of
whether the total number of papers published by countries and
institutions should be considered as an accurate means of
evaluating their research performance. More than 120,000 papers
are published annually on cancer research [20], but drugs with the
properties of imatinib constitute exceptional discoveries. The
contributions made by countries and institutions to the total
number of papers published on cancer research are therefore
unlikely to be a sound indicator of their actual contribution to the
progress of cancer treatment. For this to be correct, breakthroughs
should occur in proportion to the total number of papers published
across all countries and institutions, a condition which has never
been demonstrated.
The discussion of indicators of research performance is more
complex than just a numerical comparison as many of the total
number of papers are important and necessary to researchers even
if these papers do not directly report on scientific progress. In fact,
researchers value these papers. However, the larger society, which
pays for the research, is interested in tangible evidence of progress,
in both technological and basic research, not in the intermediate
steps (this is a short description of a complex problem; see, for
example [5,21,22]). Many of these intermediate steps may be
considered exploratory research that leads nowhere. Research in
the natural sciences is full of exciting lines of investigation that are,
in the end, abandoned and superseded by others that are often
completely different. Going back to the example of syphilis, the
first treatment applied was mercury, which was replaced by
bismuth, which was replaced by Salvarsan, which was replaced by
penicillin; bismuth is being used again, now to kill the bacterium
that causes gastric ulcers [23]. Research on the chemotherapeutic
properties of mercury would be unjustified in light of current
knowledge, but a similar conclusion does not apply to bismuth.
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These details of the discovery process are complex and rarely of
interest to the wider society, which needs solutions rather than
results of exploratory research of possible solutions with unknown
probabilities of success.
According to this line of reasoning, indicators of research
performance should reflect the substantive contributions made to
scientific progress; the relative rates at which two institutions make
important discoveries should be considered first in comparing their
scientific performance. Therefore, papers reporting real scientific
progress should be the basis of research evaluations, even though
these papers represent but a small proportion of all published
papers. The higher the proportion of these papers, the better rated
the research performance. It must be underscored, however, that
this conclusion applies to institutions with many researchers. In
evaluating individual researchers, the analysis must be different,
and the contributions made to the intermediate steps of research
must be considered. The main reason is statistical, because
important discoveries are low frequency events and even the most
highly capable researchers are not assured of achieving even a
single such discovery. The capability of a researcher is therefore
established as a probability of achieving an important discovery,
which can in turn be estimated from the researcher’s success in
normal research.
The only practical approach to estimating the number of papers
that report scientific progress is citation counts, despite the number
of technical questions the method raises [24]. Assuming that
papers which report important breakthroughs are highly cited–as
is demonstrated, for instance, by the high number of citations of
the crucial papers of Nobel Prize winners [25,26]–the resulting
working hypothesis is that indicators of scientific performance for
countries and institutions should be based on highly cited papers.
If this hypothesis were correct, indicators that consider the total
number of papers might give an erroneous estimation of research
performance. Exceptionally, this estimation would be correct in
countries with similarly efficient research systems [27].
Methods
The data-collection methods used in this study were described
in a previous paper [9]. In brief, I used the Web of Science
database, restricted to the Science Citation Index Expanded
database, and the Essential Science IndicatorsSM (ESI) resource in
Thomson Reuters’ ISI Web of Knowledge (http://isiknowledge.
com). To retrieve national publications (single-country papers with
authors from the involved university), the name of the university
was entered in the ‘‘Address’’ search field with the name of the
corresponding country using the Boolean operator ‘‘SAME’’ and
followed by the names of the remaining 22 countries with the
highest number of publications according to the ESI using the
Boolean operator ‘‘NOT’’. To restrict the search to research
articles, the option ‘‘Article’’ was selected in the ‘‘Document
Type’’ search field. Most searches were restricted to a single year
using the ‘‘Year Published’’ search field. The minimum number of
citations needed for the publications of a certain year to belong to
the percentile ranges 1% and 0.1% are recorded in the percentiles
table of the Baselines menu of the ESI. For this study, except in
Figure 1 and Table 1, the percentile breakdowns for ‘‘All Fields’’
were used. After each search, the retrieved papers were sorted by
the number of times cited, starting with the most-cited paper, and
the number of papers in each percentile was determined by the
rank number of the last paper that had the required minimum
number of citations according to the percentiles table in the ESI
Baselines menu. When necessary, a Marked List was created for
these papers. Next, the total number of citations and average
citations per item were obtained using the ‘‘Create Citation
Report’’ feature.
The data summarized in Figure 1 and Table 1 were obtained
using the Subject Area feature of the Advanced Search of the Web
of Science, SU = (Chemistry). The data were drawn from two
consecutive years, 2002 and 2003, to increase the number of
papers included in the sample. In Figure 1 the data of the two
years are shown together; in Table 1 the data of the two years were
treated independently and the results were then added together.
Approximately half of the papers recorded by the Science Citation
Index Expanded database for MIT in chemistry are Abstracts of
Figure 1. Frequency distribution of citations to the scientific
publications in chemistry of two universities. MIT (A) and
Complutense University of Madrid (B) in 2002 and 2003 in the field of
chemistry. The number of citations of the papers published in two years
are recorded together and plotted using a logarithmic scale for
citations. Publications with more than 126 citations are marked as
highly cited.
doi:10.1371/journal.pone.0047210.g001
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Papers of the American Chemical Society with zero citations; these
papers were not counted.
Except for Figure 1 and Table 1, all of the bibliometric data
reported in this study were obtained between August 8 and August
20, 2011. During these searches the ESI database was updated as
of July 1, 2011. The data recorded in Figure 1 and Table 1 were
obtained in June 2012.
Results
Frequency of Important Breakthroughs
The conclusion that indicators of research performance for
countries and institutions should be based on highly cited papers
raises a question about the citation level of these papers. This level
is important because it determines the proportion of papers that
are included in the evaluation, which involves the first question of
this report.
As a case study meant to facilitate an examination of this
proportion and the associated number of citations of the involved
papers, I will use the abovementioned example of the treatment of
chronic myelogenous leukemia. I chose to analyze papers
published in 2001, as this was the year in which the most-cited
paper about the research, which led to the discovery of imatinib
[29], was published. The selected case study presented a technical
problem in that papers on this topic are distributed across two
fields of research in the ESI database, Clinical Medicine and
Molecular Biology & Genetics, which have different percentile
breakdowns. In the less restrictive field, Clinical Medicine, the 1%
and 0.1% breakdowns for 2001 were 192 and 585 citations,
respectively, and I used these breakdowns. A search for the topic
‘‘leukemia’’ retrieved 8,247 papers, of which 631 were reviews and
5,829 were articles. The 8,247 papers received 218,945 citations
(mean = 26.6). The most-cited paper was that already mentioned
[29], which was cited 2,150 times. There were 17 papers in the top
0.1% of highly cited papers, which received a total of 18,761
citations (mean = 1,104), and 120 papers in the top 1% of highly
cited papers, which received a total of 48,274 citations
(mean = 402). The interesting scientometric question is how many
of these published papers report on important breakthroughs,
whether they represent scientific or clinical advances. I did not try
to answer this question by conducting a survey among researchers.
However, considering the activity in the field and the major
repercussions of any significant advance in publications about
cancer research, I would expect that no papers that did not reach
the top 0.1%, and perhaps not even all the papers in that
percentile, reported important breakthroughs. According to this
estimate, only 0.2% of the published papers on leukemia in 2001
may have reported important breakthroughs; although these
papers were very highly cited, they received only 8.6% of the
citations of all papers.
These small percentages demonstrate that indicators based on
the total number of papers may fail completely to recognize the
institutions that make greater contributions to the field of leukemia
research.
Comparing Two Very Different Universities
A more general approach to address the question about the
citation level that delimits the papers that should be counted for
research evaluations is the comparison of two universities with
very different levels of research performance. For this purpose, the
two universities that I compared above, MIT and Complutense
University of Madrid, meet the indicated requirements. Consid-
ering that the ratio between research investments is in excess of
10:1 and taking into account the expected performance of
researchers, a reliable indicator of research performance could
be as great as 50 times higher for MIT than for Complutense
University.
To perform the study I chose the field of chemistry because
projects of ‘‘big science’’ and papers involving authors from many
countries are less frequent in this field than they are in physics or
biology. Comparing MIT to Complutense University, the ratios
between the total number of papers, 616 versus 422; or citations,
37,701 versus 8,154; or the mean number of citations per paper,
61.1 versus 19.3, varied from 1.5 to 4.6, all figures that are far
from the abovementioned value of 50. This finding indicates that
indicators calculated from all published papers are unlikely to
reveal the actual research performance of universities. A compar-
ison of the frequency distribution of citations (Figure 1 and Table 1)
indicates that even considering the share of world’s top 1% of cited
papers, the expected differences between MIT and Complutense
University are not clearly revealed.
Basic Data of 18 Universities
Next, I selected 18 universities of different countries and
research levels according to SCImago and CWTS university
rankings, including three US universities: MIT, Cornell Univer-
sity, and The University of Utah. All universities included in the
study are well-known universities in their respective countries but
are not necessarily the highest ranked institutions in each country.
The Indian Institute of Technology consists of several autonomous
universities; data for the institute as a whole were used for this
study.
Table 2 summarizes the research activities of the selected
universities in terms of the number of papers published in 2005
and the number of citations of those papers as of the search date;
Table 3 summarizes the corresponding parameters for the papers
of each university in the world’s top 1% of cited papers in 2005.
Both tables show national and multinational papers separately.
Ordering the universities using the number of citations, the
resultant ranking lists were highly similar; both tables are shown
ordered as in Table 3 concerning national papers. The most
striking difference between the two tables was the variation in the
number of citations from the most- to the least-cited university.
For example, in Table 2, national papers, the number of citations
varied from 103,095 for MIT to 10,790 for the National
Autonomous University of Me´xico; the corresponding highest
and lowest values in Table 3 were from 46,165, for MIT, to 317,
for the National Autonomous University of Me´xico. In terms of
the number of papers, the variation was again larger in Table 3.
For example, the number of national papers in Table 2 varied
from a high of 7,219, for Osaka, to a low of 1,164 for Paris-Sud 11;
the corresponding highest and lowest values in Table 3 were 158
for MIT and 2 for the National Autonomous University of
Me´xico, respectively.
Table 1. Scientific publications of MIT and Complutense
University of Madrid in 2002 and 2003 in the field of
chemistry: number of papers in top citation percentiles.
University All papers 10% 1% 0.1%
MIT 616 202 36 7
CUM 422 18 1 0
Papers in top citation percentiles were identified independently for 2002 and
2003; the resulting figures were then summed.
doi:10.1371/journal.pone.0047210.t001
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The mean number of citations showed low variability across
universities in all cases for both Tables 2 and 3, national and
multinational papers. The mean number of citations for the papers
that were not in the top 1% of highly cited papers can be
calculated by subtracting the numbers of papers and the numbers
of citations recorded in Tables 2 and 3 and dividing the respective
differences. These means showed very low variation between the
top and bottom universities. For national papers, for example, the
means were 14.9 and 12.1 for MIT and Cornell, respectively,
versus 10.8 and 10.0 for Paris-Sud 11 and Complutense,
respectively.
Multinational Papers
Multinational papers are omitted in the formula of the x-index
[9]. Integer counting of multinational papers is frequently used in
bibliometric studies (e.g., [28]), although the method is formally
incorrect because it inflates the paper count. For example, if 50
universities from 10 countries collaborated on a published paper,
assigning the paper once to each country and institution would
count the paper ten times in country rankings and fifty times in
institution rankings. For country evaluations, fractional counting–
i.e., allotting fractions of multinational papers and of the total
count of citations to each participating institutions–corrects the
inflation effect of integer counting on bibliometric indicators.
However, there is no way to correct for differences in scientific
leadership (see Discussion, below).
The obscuring effect of integer counting on research indicators
can be estimated by comparing the weight of multinational papers
in the bibliometric parameters. The effect was minor when all the
papers were considered, given that the ratio between the numbers
of multinational and national papers was low. For the 18
universities included in this study the multinational to national
ratio for all papers varied from 0.21 for Kyoto and Utah up to 0.86
for ETH, i.e., most or the papers are national. In contrast, for
papers in the top 1% of highly cited papers, the corresponding
ratio varied from 0.46 for Utah to 3.63 for Paris-Sud 11, i.e., most
of the papers were multinational in Paris-Sud 11. The problem
with regard to the number of citations is similar, but the
differences are even more striking. For papers in the top 1% of
highly cited papers, the ratio between citations to multinational
and national papers varied form 0.53 for MIT, to 8.02 for Paris-
Sud 11. The multinational to national ratio in the top 1% of highly
cited papers was dependent on the relative rank of the universities.
In lower-ranked universities the weight of multinational papers in
each of the two indicators, number of papers and number of
citations, was greater than for the higher-ranked universities
(compare corresponding ratios in Table 2 and 3).
A final observation regarding the top 1% of highly cited papers
was that the number of institutions participating in multinational
papers was considerably higher than that in national papers. For
example, for Sapienza, Paris-Sud 11, and Complutense, the mean
numbers of institutions participating in national papers were, 4.9,
3.8, and 1.4, respectively, while the means for multinational papers
were 17, 13 and 10, respectively.
Review Papers
Review papers were also concentrated in the top 1% of highly
cited papers. Table 4 provides the numbers of national papers in
this percentile and the number of citations to these papers, as
retrieved from the Web of Science database using the ‘‘Document
Table 2. Scientific publications from 18 universities in 2005: number of papers and citations, and mean number of citations per
paper.
National publications Multinational publications Ratio (Multinat./Nat.)
University Papers Citations Mean Papers Citations Mean Papers Citations
MIT 3,980 103,095 25.9 1,310 49,828 38.0 0.33 0.35
Cornell 4,946 77,057 15.6 1,164 36,674 31.5 0.24 0.48
Oxford 4,779 70,745 14.8 2,496 76,810 30.8 0.52 1.09
Kyoto 6,271 77,576 12.4 1,353 31577 23.3 0.21 0.41
Toronto 6,649 75,435 11.4 3,135 76,759 24.5 0.47 1.02
Osaka 7,219 73,369 10.2 1,415 33,022 23.3 0.20 0.45
Utah 3,300 43,338 13.1 678 18,369 27.1 0.21 0.42
Stockholm 1,942 29,774 15.3 1,147 29,804 26.0 0.59 1.00
Heidelberg 2,525 31,796 12.6 1,233 37,462 30.4 0.49 1.18
Seoul Nat. 3,959 37,829 9.6 1,051 21,288 20.3 0.27 0.56
Utrecht 2,732 36,424 13.3 1,357 35,071 25.8 0.50 0.96
ETH Zurich 1,516 23,099 15.2 1,303 31,477 24.2 0.86 1.36
Melbourne 3,975 38,442 9.7 1,476 32,261 22.1 0.37 0.85
Sapienza 2,743 26,355 9.6 1,032 22,490 21.8 0.45 0.97
Indian Inst. Technology 3,264 25,290 7.8 591 8,965 15.2 0.18 0.35
Paris-Sud 11 1,164 13,652 11.7 914 23,369 25.6 0.79 1.71
Complutensea 1,485 15,415 10.4 410 7,408 18.1 0.31 0.64
Natl. Auton. Me´xicob 1,739 10,790 6.2 892 11,892 13,3 0.51 1.10
National and multinational papers are separated, and the corresponding ratios for the number of papers and citations are recorded.
aComplutense University of Madrid;
bNational Autonomous University of Me´xico.
doi:10.1371/journal.pone.0047210.t002
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Types’’ options of ‘‘Article’’ or ‘‘Review’’ (adding the two figures
given yields the number of national papers provided in Table 3).
The data in Table 4 reveal that review papers comprised a
significant proportion of the papers in the top 1% of highly cited
papers; this proportion, however, was uneven across universities.
Review papers made up only 17% of the national papers in MIT,
but that figure was 39% for ETH, 37% for Toronto University,
36% for Stockholm University, and 31% for Oxford University. In
general, the mean number of citations of review papers was higher
than that of articles, but it was neither much higher nor always
higher.
Methods, Clinical-trials, and Statistical Papers
To correct the problem created by MCTS papers, the formula
of the x-index contains a subtraction term, but this term gave rise
to negative index values for countries with less-competitive
research systems [9]. Returning to the example used above in
the field of cancer research, the problem introduced by these
papers can be demonstrated with the discovery of imatinib, likely
the most important advance in cancer research in many years.
Notably, the most highly cited paper regarding this drug [29]
received 2,150 citations since its date of publication in 2001. This
number is only 27 more citations than have been received by a
cancer statistics paper from the same year [30], and 2,275 fewer
citations than have been received by a cancer statistics paper from
2008 [31].
As described for multinational and review papers, MCTS
papers are concentrated in the top 1% of highly cited papers.
However, unlike multinational and review papers, it is difficult if
not impossible to identify and count MCTS papers. Among
similarly sized institutions MCTS papers fortunately operate as a
constant addition term in the x-index formula. If this term is
omitted the correlation coefficient between the x-index and the
number of Nobel Prizes decreases a little and the ranking order is
not affected. I examined the concentration of MCTS papers
among those papers published by universities and concluded that
the effects are a minor problem for high- or mid-ranking US
universities but are more important to European universities.
Although identifying MCTS papers by reading abstracts was not
easy, I believe that they account for a higher percentage of the
highly cited papers for countries than they do for universities,
perhaps due to the large number of hospitals and government
agencies which produce clinical trials and statistical studies.
In summary, to rank universities the subtraction term in the
formula of the x-index can be eliminated. Although this new x-
index for universities will overvalue some lower-ranked universi-
ties, the problem created by MCTS papers does not have a better
solution.
The Top 1% and 0.1% of Highly Cited Papers
To gain a more complete understanding of the information able
to be extracted from the number of publications in the top 1% of
highly cited papers, three additional parameters are shown in
Table 5: the number of publications in the top 0.1% of highly cited
papers, the 1% index, and 0.1%:1% ratio. The 1% index provides
the fraction of the total number of publications that reach the top
1% of highly cited papers, which characterizes the size of the tail
with reference to the total number of papers. The 0.1%:1% ratio
Table 3. Scientific publications among the world’s top 1% of highly cited papers from 18 universities in 2005: number of papers,
citations, and mean number of citations per paper.
National publications Multinational publications Ratio (Multinat./Nat.)
University Papers Citations Mean Papers Citations Mean Papers Citations
MIT 158 46,165 292 88 24,570 279 0.56 0.53
Cornell 97 18,241 188 64 15,964 249 0.66 0.88
Oxford 79 17,466 221 115 30,811 268 1.46 1.76
Kyoto 56 12,864 230 34 9,313 274 0.61 0.72
Toronto 59 10,117 172 105 24,632 235 1.78 2.43
Osaka 39 9,721 249 51 12,213 240 1.31 1.26
Utah 50 8,194 164 23 7,550 328 0.46 0.92
Stockholm 25 5,808 232 45 9,651 214 1.80 1.66
Heidelberg 22 4,629 210 47 14,117 300 2.14 3.05
Seoul National 24 4,226 176 24 5,618 234 1.00 1.33
Utrecht 26 4,209 162 43 11,208 261 1.65 2.66
ETH Zurich 18 2,996 166 38 8,324 219 2.11 2.78
Melbourne 18 2,527 140 38 8,209 216 2.11 3.25
Sapienza 13 2,461 189 27 5,725 212 2.08 2.33
Indian Inst. Technology 10 1,773 182 10 2,355 236 1.00 1.33
Paris-Sud 11 8 1,069 134 29 8,573 296 3.63 8.02
Complutensea 4 614 154 7 1,732 247 1.75 2.82
Natl. Aunton. Me´xicob 2 317 159 6 886 148 3.00 0.93
National (single-country) and multinational publications were counted separately; the corresponding ratios for the two categories of papers are recorded in the last two
columns.
aComplutense University of Madrid;
bNational Autonomous University of Me´xico.
doi:10.1371/journal.pone.0047210.t003
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provides the proportion of the number of publications that reach
the top 0.1% of highly cited papers to the number of papers in the
top 1% of highly cited papers, which informs the shape of the 1%
high-citation tail. Table 5 records these parameters independently
for national and multinational papers.
Although Table 5 represents only a preliminary study to be
completed disaggregating the data by research fields (as in
Table 1 for chemistry) and with statistical analyses, some clear
conclusions can be drawn from these preliminary data. In
national publications, the 1% index varied widely across
universities, from 4.9 for MIT and 2.2 for Cornell University
to 0.2 for the Indian Institute of Technology and 0.1 for the
National Autonomous University of Me´xico. In comparison to
the 1% index, the 0.1%:1% ratio varied far less, from 2.0 to
0.4, with no apparent association to the values of the 1% index.
The values of both parameters did not separate from the
nominal mean value of 1.0 very much and varied almost
symmetrically above and below this mean value. Multinational
publications were notably different, especially in the 1% index,
which in 15 out of 18 universities was 2–6 times above the
nominal mean value of 1. With the exception of MIT, in which
the difference is small, the research performance of universities
with the 1% index is assessed far more favorably when
considering multinational rather than national publications.
The h-index does not Distinguish the Highest Citation
Percentiles
Unlike other conventional scientometric indicators, the h-index
is calculated using only the most-cited papers [32]. However, the
h-index does not correlate with the number of Nobel Prize
achievements or with the x-index [9] and, as with many other
conventional indices, it implies small performance differences
between countries and institutions that are research leaders and
those at a lower research level [33]. To further investigate why the
h-index does not provide the expected differences between
countries and institutions in research performance, I examined
the h-core papers from the top- and bottom-ranked universities
included in the present study. I first eliminated multinational and
review papers, but this modification did not appreciably increase
the differences between the h-index values for the top and bottom
universities. I then examined the percentile positions of the h-core
papers with respect to citation distribution, for both a single year,
2005, and for the entire 10-year period covered by the ESI
database, 2001–2010. The results were clear, while most h-core
papers were in the top 1% of highly cited papers in top-ranked
universities, very few were in the top 1% for bottom-ranked
universities.
Returning to the comparison of MIT and Complutense
University, their h-index values were 115 and 42, respectively,
for 2005, when considering only national articles. This indicates
an unconvincing research performance ratio of 3:1. The relevant
fact that explains why the h-index obscures the differences between
these two universities is that while all the MIT h-core papers were
in the top 1% of highly cited papers, only three out of the 42 h-
core papers of Complutense University were in the top 1%.
In sum, according to the citation distribution, the h-index is
much more rigorous for prestigious institutions than for institutions
with a lower level of research.
Discussion
The first question addressed in this study is about the proportion
of all scientific publications that are involved in driving the
scientific progress. The x-index is calculated considering only the
papers that are included in the world’s top 1% of cited papers and
this amount of papers is very restrictive in comparison to
indicators that consider all papers. Surprisingly, a reasonably
answer to the posed question is that very few of those in the world’s
top 1% of cited papers are really relevant for the progress of
science. According with this conclusion the x-index predicts the
size of a population of papers that is much smaller than the sample
of papers from which it is calculated. Especially, the x-index was
formulated to predict the number of Nobel Prize achievements,
which are obviously far less than the 1% of the papers. The best
explanation for this prediction is that it is possible because the
share of highly cited papers follows a power law [9], in which the
frequency of the less frequent events can be predicted from the
known frequencies of others that are more frequent, top 1% and
0.1% of highly cited papers.
Additionally, the finding that more than 99% of the published
papers do not most likely report on important breakthroughs but
do receive more than 90% of the total number of citations strongly
suggest that research performance should be evaluated without
considering that lower-cited 99% of published papers. If all papers
are considered, the real scientific differences between countries
and institutions are blurred.
The second part of this study aimed to know the number of
papers from universities that are in the world’s top percentiles of
highly cited papers and the proportion of multinational, reviews,
Table 4. National scientific publications among the world’s
top 1% of highly cited papers from 18 universities in 2005
recorded in the database as articles or reviews: number of
papers, citations, and mean number of citations per paper.
Articles Reviews
University Papers Citations Mean Papers Citations Mean
MIT 131 40,307 308 27 5,858 217
Cornell 71 13,244 187 26 4,997 192
Oxford 54 11,738 217 25 5,728 229
Kyoto 48 10,082 210 8 2,782 348
Toronto 37 6,390 173 22 3,727 169
Osaka 32 7,457 233 7 2,264 323
Utah 40 6,420 161 10 1,774 177
Stockholm 16 2,711 169 9 3,097 344
Heidelberg 14 2,911 208 8 1,718 215
Seoul National 20 3,227 161 4 999 250
Utrecht 21 3,464 165 5 745 149
ETH Zurich 11 1,840 167 7 1,156 165
Melbourne 14 1,938 138 4 589 147
Sapienza 10 1,781 178 3 680 227
Indian Inst.
Technology
5 684 137 5 1,089 218
Paris-Sud 11 6 848 141 2 221 111
Complutensea 3 477 159 1 137 137
Natl. Auton.
Me´xicob
0 0 – 2 317 159
aComplutense University of Madrid;
bNational Autonomous University of Me´xico.
doi:10.1371/journal.pone.0047210.t004
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and MCTS papers. A final aim was to investigate the possibility of
simplifying the formula of the x-index for universities. For this
purpose, the size differences between the 18 universities included
in the study are not large and the reported counts may be treated
as size-independent.
As a general trend, the rankings of the 18 universities are sound,
independently of whether they are based on the counts of papers
or citations, either considering the total number of papers or the
top 1% of highly cited papers. However, to judge these rankings
and to analyze if the ranking parameters accurately reflect the
universities’ participation in the progress of science, the variation
between the highest and the lowest values of the involved ranking
parameter is the most important issue. This variation ranged from
150:1 for the citation counts of national papers in the top 1% of
highly cited papers to 4:1 for counts of the total number of papers
(Tables 2 and 3).
To select a ranking parameter it is worth clarifying that
counting papers is better than counting citations if the goal is to
rank universities on the basis of their research performance. The
reason is statistical: the numbers of papers in the top 1% or 0.1%
of highly cited paper for different years are entirely equivalent,
which allows to use these counts for statistical analyses. This
possibility does not apply to citation counting, unless the number
of citations is normalized to correct for the time dependence of
citations counting.
Review, MCTS, and multinational papers are all concentrated
in the top 1% of highly cited papers. Review papers may be of
several types and may be important for fixing knowledge, but they
rarely report on important breakthroughs. However, review
papers are not as significant a problem because their effect on
the indicators for universities seems to be low and they can easily
be omitted from counts by restricting database searches. In
contrast, MCTS papers cannot currently be identified using
bibliometric procedures and therefore cannot be eliminated. For
the evaluation of universities the existence of these papers may be
ignored, as described above.
Highly cited multinational papers make up a large proportion of
the number of papers in the high-citation percentiles of the citation
distribution for lower-ranked universities (Table 3). Consequently,
in research indicators based on the papers in the high-citation
percentiles, multinational papers increase the apparent competi-
tiveness of the lower-ranked universities far more than they do in
the case of the higher-ranked universities. Therefore, in these
indicators, any errors made in determining what procedure should
be applied to rate highly cited multinational papers may mislead
the evaluations of lower-ranked universities. In the absence of a
convenient counting method for multinational papers their
omission from indices based on highly cited papers is an obvious
solution [9].
This omission may be controversial because the described
effects can potentially be corrected for with fractional counting. In
fractional counting, if n countries or institutions participate in
producing a paper, each country or institution receives 1/n of the
credit [34–36]. This procedure is formally correct but does not
Table 5. Characterization of the 1% high-citation tail: the 1% index characterizes the size of the tail and the 0.1%:1% ratio
characterizes the shape of the tail.
National publicationsa Multinational publicationsa
University Total 1% HCb 0.1% HCb 1% indexc
0.1%:1%
ratiod Total 1% HCb 0.1% HCb 1% indexc
0.1%:1%
ratiod
MIT 2,687 131 22.0 4.9 1.7 1,196 77 11.0 6.4 1.4
Cornell 3,125 70 6.0 2.2 0.9 967 50 5.7 5.2 1.1
Oxford 2,876 50 4.7 1.7 0.9 2,010 89 11.7 4.4 1.3
Kyoto 4,771 40 4.0 0.8 1.0 1,195 45 2.0 3.8 0.4
Toronto 3,943 39 2.0 1.0 0.5 2,309 92 14.3 4.0 1.6
Osaka 5,516 30 3.7 0.5 1,2 1,287 43 7.7 3.3 0.8
Utah 2,085 28 2.0 1.3 0.7 527 18 2.3 3.4 1.3
Stockholm 1,364 14 1.0 1.0 0.7 905 37 8.0 4.1 2.2
Heidelberg 1,649 16 2.0 1.0 1.3 962 37 9.0 3.8 2.4
Seoul National 3,100 22 2.0 0.7 0.9 985 21 3.7 2.1 1.8
Utrecht 1,875 18 1.0 1.0 0.6 1,117 33 2.3 3.0 0.7
ETH Zurich 1,089 14 2.0 1.3 1.4 1,187 28 3.0 2.4 1.1
Melbourne 2,497 19 0.7 0.8 0.4 1,174 33 4.7 2.8 1.4
Sapienza Roma 1,881 9 1.0 0.5 1.1 984 20 2.0 2.0 1.0
Indian Inst. Technology 2,860 5 0.0 0.2 2 614 5 0.0 0.8 2
Paris-Sud 11 1,021 6 1.2 0.6 2.0 823 21 3.0 2.6 1.4
Complutensee 1,201 5 0.0 0.4 2 340 5.3 0.3 1.6 0.6
Natl. Auton. Me´xicof 1,395 1 0.0 0.1 2 789 8 1.7 1.0 2.1
aMeans of 2004, 2005, and 2006;
b1% and 0.1% HC, number of papers in the world’s top 1% and 0.1% of highly cited papers;
c1% index = 100 times 1% HC divided by the total number of papers;
d0.1%:1% ratio = 10 times 0.1% HC divided by 1% HC;
eComplutense University of Madrid;
fNational Autonomous University of Me´xico.
doi:10.1371/journal.pone.0047210.t005
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take into account the fact that, in collaborations between
universities from countries with different levels of scientific
achievement, the collaborations might not have been symmetrical
in terms of scientific leadership and contributions made. This
absence of symmetry is suggested both by the proportion of
multinational papers in the top 1% of highly cited papers (Table 3),
which is larger for the lower-ranked than it is for the higher-ranked
universities, and the likelihood that the quality of the research
performed by an institution is similar whether it is participating in
single-country or multinational papers. This assumption may not
be valid, but unless it is demonstrated to be false and scientific
contributions made to multinational papers are proven to be
strictly equal for all participants, fractional counting cannot be
considered the solution to rate multinational collaborations.
Fractional counting also may discourage collaborations between
highly competitive and less competitive institutions, as the former
may wish to avoid lowering their evaluation indices.
Even ignoring these considerations, the crucial point is that the
omission of multinational or multi-institutional papers from counts
is not a problem when the number of papers remaining in the
sample is sufficiently large. In that case, the parameter that best
characterizes a country or institution is a size-independent index
such as the z-index [9]. Once this index is calculated, the total
contribution of that country or institution to the advancement of
science can be estimated by multiplying the size-independent
index by the total number of papers, including the fractional
counting of multinational papers. This approach assumes that the
scientific leadership of a country or institution is the same in
multinational and national papers, as discussed above.
In the present study, I have addressed the problem of
multinational papers, but not that of multi-institutional papers.
Differences in the scientific performance of countries are perhaps
more important for most evaluations than are differences in the
scientific performance of different institutions in the same country.
However, the elimination of multi-institutional papers in rankings
institutions in the same country deserves further investigation.
As a result of these considerations, the formula of the x index for
universities is:
xu~N1z15N0:1
where N1 and N0.1 are the number of national articles in the top
1% and 0.1% of highly cited papers, respectively. The zu index has
the same formula as the z index [9] substituting the value of the xu
index for that of the x index. The new formula of the zu index
eliminating the subtraction term will produce university rankings
in which the values of the indicator are 6 units higher than those
corresponding to the z index. This increase is of little relevance for
the high z values of the higher-ranked universities but is important
for the low z values of lower-ranked universities. However, this
constant increase does affect rankings and its effect on the
indicator is a minor inconvenience considering the current
impossibility of bibliometrically eliminating MCTS papers.
The formulas of the xu and zu indices include the number of
national papers in the top 1% and 0.1% most cited papers, but
national papers in the top 0.1% of most cited papers are not found
among lower-ranked universities (Table 5). This fact precludes that
the xu and zu indices for these universities have exactly the same
mathematical meaning as in higher-ranked universities. However,
these indices remain sound indicators for ranking universities of
low research performance. In the absence of national articles in
the top 1% of highly cited papers, in any of the five successive
years that are used to calculate the x index [9], universities cannot
be ranked with the xu and zu indices. The essential issue that this
absence reflects is that these universities have a very low level of
research achievement and that they have to be evaluated by their
‘‘normal’’ research activity, e.g. counting all papers or those in the
top 10% most cited papers.
I demonstrated, above, that the proportion of h-core papers in
the 1% high-citation tail is not proportional to the value of the h-
index. Therefore, using the h-index to rank institutions or
countries does not provide a clear picture of the differences in
research performance among the to-be-ranked institutions or
countries. This consideration is much more important for
institutions than for researchers. I have asserted in this study that
researchers cannot be evaluated using the same indices as are
applied to institutions or countries. Researchers are best evaluated
by measuring their capability while evaluations of institutions
should measure the achievement of important breakthroughs.
Because important breakthroughs are low frequency events, the
difference is statistical: the achievements of one versus the
achievements of 1,000 or more.
Research indicators derived from highly cited papers are field-
dependent; the research fields with the highest citation rates have
the highest influence in the indicators of multidisciplinary
institutions such as universities. This problem is common with
any index for institutions and journals, and can be solved by
analyzing each paper in its corresponding field of research (as has
been done in Figure 1 and Table 1). It is also possible to normalize
the number of citations across fields (see, for example, [34,37–40]).
However, applying this approach introduces potential risks in that
institutional rankings then depend on the number of references in
each paper, which in turn depends on authors’ behavior, which in
turn might be influenced by the evaluation process. Experience
with the impact factor (e.g., [41]) shows that scientific evaluations
must estimate research performance in a way that depends as little
as possible on authorial decisions that are not related to research
goals because unintended consequences are likely to occur [6,7].
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